Walter Unger, MD: Follicular unit hair transplantation

Most men develop early signs of male pattern baldness by the age of 40. However, few realize that modern hair transplant techniques can be extremely effective at halting the inevitable and more noticeable balding.

Dr. Walter Unger, Professor at Mt. Sinai School of Medicine in dermatology and full-time hair restoration expert discusses the modern technique called follicular unit hair transplantation. Older techniques that caused the infamous “doll’s head” look used large plugs of hair. He explains more in the video discussion below.

 

The Samsung Galaxy tablet as a medical tool

December 21, 2010

Diabetes expert and Professor of Medicine at Mount Sinai in New York City, Zachary Bloomgarden, MD, reviews the new Samsung Galaxy Android-based tablet. He gives an overview of the general features, then discusses certain medical Apps for the doctor, such as Epocrates, and patient-focused Apps to help with diabetes control.

Zachary Bloomgarden, MD: What Victoza approval means for Byetta LAR

February 7, 2010

The HCC interviewed diabetes specialist Zachary Bloomgarden, MD about his thoughts on the newly approved GLP-1 Victoza and what it might mean for the eventual label on Byetta LAR.

The HCC Q1: Overall, was the label for Victoza better or worse than you expected?

Bloomgarden: I’m concerned at how to counsel other physicians  - and my patients - on the thyroid findings.  Ideally, some further guidance would have been provided beyond “if there is a mass in the neck look into it.”  The pancreatitis issue may be real, but does not require a change in the approach already used for Byetta, that with any non-trivial/expected GI symptoms patients should not take the drug until they have contacted their doctor.  On the pro side, the very impressive glycemic benefit, compared with multiple other agents, the weight loss, and the rather good overall tolerability are clearly expressed.

The HCC Q2: Are the pancreatitis sections expressing a legitimate concern in your view?

Bloomgarden: Yes, as above

The HCC Q3: What does this mean for Byetta LAR regarding pancreatitis and other safety issues listed in the Victoza label?

Bloomgarden: I don’t see how Byetta LAR will not have pancreatitis cautions and I want to make sure that they have conducted sufficient human calcitonin measurements to address the concern as to whether or not there is an effect (remember with Victoza it is only seen in ~2% vs. ~1%, so large numbers of patients need to be tested).

The HCC Q4: If Byetta LAR is approved, how will it compete in pros and cons to Victoza?

Bloomgarden: Pro-Byetta is weekly rather than daily, pro-Victoza is probably a much easier injection not requiring the large needle, the reconstitution, etc.  Side effects to my mind will be the thyroid issue as above, whether it is or is not will be a big deal.

Zachary T. Bloomgarden, MD
Editor, the Journal of Diabetes
http://www3.interscience.wiley.com/journal/118902543/home
———————-
Clinical Professor
Department of Medicine
Mount Sinai School of Medicine

Zachary Bloomgarden, MD: Onglyza (saxagliptin) launch

August 5, 2009

The Bristol-Meyers Squibb drug Onglyza was recently approved by the FDA and is crucial for the company as a replacement for lost patented drugs. Plavix soon loses patent protection as well. We interviewed clinical diabetes expert and Editor of The Journal of Diabetes, Dr. Bloomgarden, about the DPP4-inhibiotr class, which included Januvia, and whether Onglyza has a better efficacy or safety profile than Januvia.

Zachary Bloomgarden, MD: The Biodel VIAject data

Zachary Bloomgarden, MD of Mount Sinai School of Medicine, New York, diabetologist, discusses the Biodel VIAject data

Zachary Bloomgarden, MD: the Onglyza launch

Diabetes expert Zachary Bloomgarden, MD of Mount Sinai medical Center in New York discusses the newly approved DPP4-inhibtor drug, Onglyza (saxagliptin) to compete with Januvia.

Zachary Bloomgarden, MD: Byetta and Avandia

Zachary Bloomgarden, MD New York City endocrinologist, discusses new insulin drugs Avandia and Byetta

Zachary Bloomgarden, MD: Continuous Glucose Monitors

Zachary Bloomgarden, MD of Mount Sinai School of Medicine, New York, diabetologist, discusses continuous glucose monitors

Zachary Bloomgarden, MD: Exanatide (Byetta) and pancreatitis

Zachary Bloomgarden, MD: Professor of medicine at Mount Sinai Medical Center, New York, discusses the relationship between exanatide (Byetta) and pancreatitis